Office of the Secretary; Notice of Meeting, 34213 [2020-11980]

Download as PDF Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices Dated: May 29, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2020–11980 Filed 6–2–20; 8:45 am] Office of the Secretary; Notice of Meeting BILLING CODE 4140–01–P lotter on DSK9F5VC42PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Task Force on Research Specific to Pregnant Women and Lactating Women. The meeting will be open to the public and held as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC). Date: June 24, 2020, 3:00 p.m. to 5:00 p.m. (EDT). Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH, 31 Center Drive, MSC 2425, Building 31, Room 2A03, Bethesda, MD 20892 (Virtual Meeting). Agenda: The Task Force is charged with providing advice and guidance to the Secretary of HHS regarding Federal activities related to identifying and addressing gaps in knowledge and research regarding safe and effective therapies for pregnant women and lactating women, including the development of such therapies and the collaboration on and coordination of such activities. The Task Force will be discussing implementation steps to carry out the recommendations made in the 2018 PRGLAC Report to the Secretary. Contact Person: Lisa Kaeser, Executive Secretary, Office of Legislation and Public Policy, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 31 Center Drive, MSC 2425, Building 31, Room 2A03, Bethesda, MD 20892, (301) 496–0536, kaeserl@mail.nih.gov. Registration: Attendees should register prior to the meeting by going to the following: https://nih.webex.com/nih/ onstage/ g.php?MTID=e7c4f50704d72bbe20584 c279a3ec07b5. Password: NICHD. Details and additional information about this meeting, prior meetings, and the Task Force’s 2018 Report and Recommendations can be found on the NICHD website for the Task Force on Research Specific to Pregnant Women and Lactating Women: https:// www.nichd.nih.gov/about/advisory/PRGLAC. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. VerDate Sep<11>2014 18:35 Jun 02, 2020 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Bacterial Pathogenesis. Date: June 30, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Richard G. Kostriken, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 20892, 240–519– 7808, kostrikr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Early and Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Agerelated Cognitive Decline. Date: June 30, 2020. Time: 11:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Unja Hayes, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301– 827–6830, unja.hayes@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR19–367: Maximizing Investigators’ Research Award (R35—Clinical Trial Optional). Date: July 1–2, 2020. Time: 9:00 a.m. to 6:00 p.m. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 34213 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anita Szajek, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301–827–6276, anita.szajek@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Aging and Development, Auditory, Vision and Low Vision Technologies. Date: July 1–2, 2020. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joseph G. Rudolph, Ph.D., Chief and Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD 20892, 301–408– 9098, josephru@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: 4D Nucleome Data Integration, Modeling, Visualization, Coordination and Organizational Centers and Hubs. Date: July 1–2, 2020. Time: 9:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joseph Thomas Peterson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 20892, 301–408– 9694, petersonjt@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Psycho/Neuropathology Lifespan Development, STEM Education. Date: July 1–2, 2020. Time: 10:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Elia K.Ortenberg, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3108, Bethesda, MD 20892, 301–827–7189, femiaee@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurogenetics and Neurological Disorders. Date: July 1, 2020. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Vilen A. Movsesyan, Ph.D., Scientific Review Officer, Center for E:\FR\FM\03JNN1.SGM 03JNN1

Agencies

[Federal Register Volume 85, Number 107 (Wednesday, June 3, 2020)]
[Notices]
[Page 34213]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11980]



[[Page 34213]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Task Force on 
Research Specific to Pregnant Women and Lactating Women.
    The meeting will be open to the public and held as a virtual 
meeting. Individuals who plan to view the virtual meeting and need 
special assistance or other reasonable accommodations to view the 
meeting, should notify the Contact Person listed below in advance of 
the meeting.

    Name of Committee: Task Force on Research Specific to Pregnant 
Women and Lactating Women (PRGLAC).
    Date: June 24, 2020, 3:00 p.m. to 5:00 p.m. (EDT).
    Place: Eunice Kennedy Shriver National Institute of Child Health 
and Human Development/NIH, 31 Center Drive, MSC 2425, Building 31, 
Room 2A03, Bethesda, MD 20892 (Virtual Meeting).
    Agenda: The Task Force is charged with providing advice and 
guidance to the Secretary of HHS regarding Federal activities 
related to identifying and addressing gaps in knowledge and research 
regarding safe and effective therapies for pregnant women and 
lactating women, including the development of such therapies and the 
collaboration on and coordination of such activities. The Task Force 
will be discussing implementation steps to carry out the 
recommendations made in the 2018 PRGLAC Report to the Secretary.
    Contact Person: Lisa Kaeser, Executive Secretary, Office of 
Legislation and Public Policy, Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, 31 Center Drive, 
MSC 2425, Building 31, Room 2A03, Bethesda, MD 20892, (301) 496-
0536, [email protected].
    Registration: Attendees should register prior to the meeting by 
going to the following: https://nih.webex.com/nih/onstage/g.php?MTID=e7c4f50704d72bbe20584c279a3ec07b5. Password: NICHD.
    Details and additional information about this meeting, prior 
meetings, and the Task Force's 2018 Report and Recommendations can 
be found on the NICHD website for the Task Force on Research 
Specific to Pregnant Women and Lactating Women: https://www.nichd.nih.gov/about/advisory/PRGLAC.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: May 29, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-11980 Filed 6-2-20; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.